Form 4 for MDT Medtronic
Accepted 2022-08-02 00:00:00 ET · period of report 2022-07-29 · accession 0001127602-22-020196 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-02 | 2022-07-29 | MDT | Martha Geoffrey | COB, CEO, Dir | D - Sale to Iss | $0.00 | -23.4K | 74.0K | -24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-07-29 | D | D | 23,410 | $0.00 | 74,026 | D | — | — | (F1) Represents shares of performance-vesting restricted stock granted in July 2019 and earned dividend equivalent units that have been forfeited based on the Company's failure to meet the cumulative three year non-GAAP diluted earnings per share ("EPS") growth performance target. (F2) This balance increased by 1,600 shares due to exempt acquisitions through dividend reinvestment. |